Brian C. Broderick’s AbbVie ABBV Stock Holding History

Brian C. Broderick’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.53M	Buy	14,011 +180	+1%	+$38.7K	0.55%	40
2026 Q1	$3.01M	Buy	13,831 +506	+4%	+$112K	0.55%	40
2025 Q4	$3.04M	Sell	13,325 -45	-0.3%	-$10.3K	0.58%	39
2025 Q3	$3.1M	Buy	13,370 +304	+2%	+$61.9K	0.59%	37
2025 Q2	$2.43M	Sell	13,066 -12	-0.1%	-$2.23K	0.48%	42
2025 Q1	$2.74M	Sell	13,078 -25	-0.2%	-$4.86K	0.56%	39
2024 Q4	$2.33M	Hold	13,103	–	–	0.46%	40
2024 Q3	$2.59M	Sell	13,103 -20	-0.2%	-$3.73K	0.51%	42
2024 Q2	$2.25M	Buy	13,123 +511	+4%	+$84.6K	0.46%	45
2024 Q1	$2.3M	Buy	12,612 +1,673	+15%	+$288K	0.49%	40
2023 Q4	$1.7M	Sell	10,939 -1,258	-10%	-$183K	0.42%	41
2023 Q3	$1.82M	Sell	12,197 -70	-0.6%	-$10.3K	0.5%	40
2023 Q2	$1.65M	Hold	12,267	–	–	0.44%	41
2023 Q1	$1.95M	Sell	12,267 -70	-0.6%	-$10.7K	0.55%	40
2022 Q4	$1.99M	Sell	12,337 -675	-5%	-$104K	0.59%	40
2022 Q3	$1.75M	Sell	13,012 -225	-2%	-$32.3K	0.55%	43
2022 Q2	$2.03M	Sell	13,237 -2,075	-14%	-$317K	0.62%	42
2022 Q1	$2.48M	Sell	15,312 -590	-4%	-$85.7K	0.63%	42
2021 Q4	$2.15M	Sell	15,902 -10	-0.1%	-$1.18K	0.52%	43
2021 Q3	$1.72M	Sell	15,912 -65	-0.4%	-$7.43K	0.46%	48
2021 Q2	$1.8M	Sell	15,977 -120	-0.7%	-$13.5K	0.48%	49
2021 Q1	$1.74M	Sell	16,097 -15	-0.1%	-$1.6K	0.5%	45
2020 Q4	$1.73M	Hold	16,112	–	–	0.51%	46
2020 Q3	$1.41M	Buy	16,112 +1,257	+8%	+$118K	0.45%	49
2020 Q2	$1.46M	Sell	14,855 -660	-4%	-$58.1K	0.49%	48
2020 Q1	$1.18M	Sell	15,515 -10	-0.1%	-$852	0.47%	49
2019 Q4	$1.38M	Sell	15,525 -925	-6%	-$76.8K	0.45%	51
2019 Q3	$1.25M	Sell	16,450 -1,900	-10%	-$130K	0.43%	51
2019 Q2	$1.33M	Sell	18,350 -725	-4%	-$57K	0.47%	49
2019 Q1	$1.54M	Sell	19,075 -445	-2%	-$36.4K	0.55%	48
2018 Q4	$1.8M	Sell	19,520 -935	-5%	-$82.2K	0.76%	42
2018 Q3	$1.93M	Sell	20,455 -150	-0.7%	-$14.2K	0.66%	45
2018 Q2	$1.91M	Sell	20,605 -750	-4%	-$73.2K	0.7%	44
2018 Q1	$2.02M	Sell	21,355 -820	-4%	-$90.1K	0.76%	43
2017 Q4	$2.14M	Sell	22,175 -4,710	-18%	-$444K	0.78%	42
2017 Q3	$2.39M	Sell	26,885 -1,225	-4%	-$93.3K	0.86%	38
2017 Q2	$2.04M	Sell	28,110 -450	-2%	-$30.3K	0.75%	44
2017 Q1	$1.86M	Sell	28,560 -1,550	-5%	-$97.4K	0.76%	42
2016 Q4	$1.89M	Sell	30,110 -55	-0.2%	-$3.36K	0.82%	39
2016 Q3	$1.9M	Sell	30,165 -1,170	-4%	-$75.7K	0.81%	39
2016 Q2	$1.94M	Sell	31,335 -175	-0.6%	-$10.7K	0.82%	41
2016 Q1	$1.8M	Buy	31,510 +1,775	+6%	+$98.9K	0.78%	44
2015 Q4	$1.76M	Buy	29,735 +2,510	+9%	+$145K	0.79%	44
2015 Q3	$1.48M	Sell	27,225 -2,385	-8%	-$155K	0.69%	53
2015 Q2	$1.99M	Sell	29,610 -100	-0.3%	-$6.53K	0.85%	43
2015 Q1	$1.74M	Sell	29,710 -1,380	-4%	-$83.4K	0.72%	50
2014 Q4	$2.03M	Buy	31,090 +2,020	+7%	+$127K	0.86%	43
2014 Q3	$1.68M	Sell	29,070 -260	-0.9%	-$14.4K	0.75%	45
2014 Q2	$1.66M	Buy	29,330 +360	+1%	+$18.9K	0.76%	44
2014 Q1	$1.49M	Hold	28,970	–	–	0.73%	43
2013 Q4	$1.53M	Hold	28,970	–	–	0.76%	42
2013 Q3	$1.29M	Sell	28,970 -480	-2%	-$21.3K	0.72%	47
2013 Q2	$1.22M	Buy	+29,450	New	+$1.29M	0.73%	46

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brian C. Broderick's ABBV Position: Q2 2026 in Review

Brian C. Broderick increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $38.7K and bringing the position to 14,011 shares worth $3.53M. The position accounts for 0.55% of the portfolio, ranked #40.

Brian C. Broderick first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Brian C. Broderick held 14,011 shares of AbbVie worth $3.53M as of Q2 2026.
Brian C. Broderick bought 180 AbbVie shares in Q2 2026, an estimated $38.7K.
AbbVie made up 0.55% of Brian C. Broderick's portfolio in Q2 2026, its #40 holding.
Brian C. Broderick first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brian C. Broderick's 13F filing for Q2 2026, filed 11 Aug 2026.